WRDEF yields 6.52% · JNJ yields 2.13%● Live data
📍 WRDEF pulled ahead of the other in Year 1
Combined, WRDEF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of WRDEF + JNJ for your $10,000?
At Wereldhave, we're reinventing shopping centers. Our centers are places where people go, not only to shop, but also to work, relax and spend time with friends and family. We now own and operate 30 center locations across the Netherlands, Belgium and France combining leisure, entertainment, health & beauty and food & drink with more traditional retail. We choose centers close to cities that are well connected to public transport and where we can offer free parking. Our centers are anchored around food retail each has at least one hypermarket or two to three supermarkets. Our centers are places where people go, not only to shop, but also to meet and relax with friends and family. We take a deliberately long-term approach. Our aim is to deliver attractive returns for our investors, create positive value for local communities and other stakeholders and, over time, increase the value of our investments. As a business, consumers are at the heart of everything we do.
Full WRDEF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.